Go Pro

Elevance Health (ELV) Competitors

Elevance Health logo
$400.63 +2.41 (+0.60%)
Closing price 08/14/2026 03:59 PM Eastern
Extended Trading
$400.52 -0.11 (-0.03%)
As of 08/14/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ELV vs. CNC, MOH, UNH, HUM, and OSCR

Should you buy Elevance Health stock or one of its competitors? Elevance Health's main competitors and comparable companies include Centene (CNC), Molina Healthcare (MOH), UnitedHealth Group (UNH), Humana (HUM), and Oscar Health (OSCR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "managed healthcare" industry.

How does Elevance Health compare to Centene?

Centene (NYSE:CNC) and Elevance Health (NYSE:ELV) are both large-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, media sentiment, earnings, dividends and risk.

Centene has a beta of 1.08, meaning that its stock price is 8% more volatile than the broader market. Comparatively, Elevance Health has a beta of 0.68, meaning that its stock price is 32% less volatile than the broader market.

Centene currently has a consensus price target of $69.15, indicating a potential upside of 2.40%. Elevance Health has a consensus price target of $440.90, indicating a potential upside of 10.05%. Given Elevance Health's stronger consensus rating and higher probable upside, analysts clearly believe Elevance Health is more favorable than Centene.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Centene
2 Sell rating(s)
9 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.40
Elevance Health
0 Sell rating(s)
8 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.65

Elevance Health has lower revenue, but higher earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Centene$202.94B0.16-$6.67B-$10.44N/A
Elevance Health$199.13B0.44$5.66B$22.5017.81

93.6% of Centene shares are owned by institutional investors. Comparatively, 89.2% of Elevance Health shares are owned by institutional investors. 0.4% of Centene shares are owned by company insiders. Comparatively, 0.3% of Elevance Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Elevance Health has a net margin of 2.47% compared to Centene's net margin of -2.51%. Elevance Health's return on equity of 14.64% beat Centene's return on equity.

Company Net Margins Return on Equity Return on Assets
Centene-2.51% 12.12% 3.20%
Elevance Health 2.47%14.64%5.22%

In the previous week, Centene had 9 more articles in the media than Elevance Health. MarketBeat recorded 15 mentions for Centene and 6 mentions for Elevance Health. Elevance Health's average media sentiment score of 1.34 beat Centene's score of 0.87 indicating that Elevance Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Centene
6 Very Positive mention(s)
1 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Elevance Health
4 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Elevance Health beats Centene on 11 of the 17 factors compared between the two stocks.

How does Elevance Health compare to Molina Healthcare?

Molina Healthcare (NYSE:MOH) and Elevance Health (NYSE:ELV) are both large-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, analyst recommendations, risk, media sentiment, earnings and dividends.

98.5% of Molina Healthcare shares are held by institutional investors. Comparatively, 89.2% of Elevance Health shares are held by institutional investors. 1.4% of Molina Healthcare shares are held by company insiders. Comparatively, 0.3% of Elevance Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Molina Healthcare has a beta of 0.75, suggesting that its stock price is 25% less volatile than the broader market. Comparatively, Elevance Health has a beta of 0.68, suggesting that its stock price is 32% less volatile than the broader market.

Molina Healthcare currently has a consensus price target of $202.44, suggesting a potential downside of 4.62%. Elevance Health has a consensus price target of $440.90, suggesting a potential upside of 10.05%. Given Elevance Health's stronger consensus rating and higher possible upside, analysts clearly believe Elevance Health is more favorable than Molina Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Molina Healthcare
2 Sell rating(s)
11 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.18
Elevance Health
0 Sell rating(s)
8 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.65

Elevance Health has a net margin of 2.47% compared to Molina Healthcare's net margin of -0.02%. Elevance Health's return on equity of 14.64% beat Molina Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Molina Healthcare-0.02% 3.73% 0.97%
Elevance Health 2.47%14.64%5.22%

In the previous week, Molina Healthcare had 17 more articles in the media than Elevance Health. MarketBeat recorded 23 mentions for Molina Healthcare and 6 mentions for Elevance Health. Elevance Health's average media sentiment score of 1.34 beat Molina Healthcare's score of 1.10 indicating that Elevance Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Molina Healthcare
10 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Elevance Health
4 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Elevance Health has higher revenue and earnings than Molina Healthcare. Molina Healthcare is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Molina Healthcare$44.52B0.25$472M-$0.18N/A
Elevance Health$199.13B0.44$5.66B$22.5017.81

Summary

Elevance Health beats Molina Healthcare on 12 of the 17 factors compared between the two stocks.

How does Elevance Health compare to UnitedHealth Group?

UnitedHealth Group (NYSE:UNH) and Elevance Health (NYSE:ELV) are both large-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, media sentiment, profitability, valuation, analyst recommendations, institutional ownership, earnings and risk.

UnitedHealth Group has a beta of 0.62, meaning that its stock price is 38% less volatile than the broader market. Comparatively, Elevance Health has a beta of 0.68, meaning that its stock price is 32% less volatile than the broader market.

87.9% of UnitedHealth Group shares are held by institutional investors. Comparatively, 89.2% of Elevance Health shares are held by institutional investors. 0.2% of UnitedHealth Group shares are held by company insiders. Comparatively, 0.3% of Elevance Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

UnitedHealth Group currently has a consensus target price of $455.92, suggesting a potential upside of 13.55%. Elevance Health has a consensus target price of $440.90, suggesting a potential upside of 10.05%. Given UnitedHealth Group's stronger consensus rating and higher probable upside, analysts clearly believe UnitedHealth Group is more favorable than Elevance Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
UnitedHealth Group
0 Sell rating(s)
5 Hold rating(s)
20 Buy rating(s)
2 Strong Buy rating(s)
2.89
Elevance Health
0 Sell rating(s)
8 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.65

UnitedHealth Group pays an annual dividend of $9.28 per share and has a dividend yield of 2.3%. Elevance Health pays an annual dividend of $6.88 per share and has a dividend yield of 1.7%. UnitedHealth Group pays out 59.7% of its earnings in the form of a dividend. Elevance Health pays out 30.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. UnitedHealth Group has increased its dividend for 15 consecutive years and Elevance Health has increased its dividend for 14 consecutive years. UnitedHealth Group is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, UnitedHealth Group had 27 more articles in the media than Elevance Health. MarketBeat recorded 33 mentions for UnitedHealth Group and 6 mentions for Elevance Health. Elevance Health's average media sentiment score of 1.34 beat UnitedHealth Group's score of 0.76 indicating that Elevance Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
UnitedHealth Group
20 Very Positive mention(s)
5 Positive mention(s)
1 Neutral mention(s)
4 Negative mention(s)
2 Very Negative mention(s)
Positive
Elevance Health
4 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

UnitedHealth Group has a net margin of 3.14% compared to Elevance Health's net margin of 2.47%. UnitedHealth Group's return on equity of 16.53% beat Elevance Health's return on equity.

Company Net Margins Return on Equity Return on Assets
UnitedHealth Group3.14% 16.53% 5.43%
Elevance Health 2.47%14.64%5.22%

UnitedHealth Group has higher revenue and earnings than Elevance Health. Elevance Health is trading at a lower price-to-earnings ratio than UnitedHealth Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
UnitedHealth Group$450.13B0.80$12.06B$15.5425.84
Elevance Health$199.13B0.44$5.66B$22.5017.81

Summary

UnitedHealth Group beats Elevance Health on 14 of the 20 factors compared between the two stocks.

How does Elevance Health compare to Humana?

Humana (NYSE:HUM) and Elevance Health (NYSE:ELV) are both large-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, valuation, institutional ownership, earnings, media sentiment, dividends, profitability and analyst recommendations.

Elevance Health has a net margin of 2.47% compared to Humana's net margin of 0.88%. Elevance Health's return on equity of 14.64% beat Humana's return on equity.

Company Net Margins Return on Equity Return on Assets
Humana0.88% 11.20% 3.94%
Elevance Health 2.47%14.64%5.22%

Humana has a beta of 0.72, meaning that its stock price is 28% less volatile than the broader market. Comparatively, Elevance Health has a beta of 0.68, meaning that its stock price is 32% less volatile than the broader market.

Elevance Health has higher revenue and earnings than Humana. Elevance Health is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Humana$129.66B0.36$1.19B$10.5736.72
Elevance Health$199.13B0.44$5.66B$22.5017.81

Humana presently has a consensus price target of $395.22, indicating a potential upside of 1.82%. Elevance Health has a consensus price target of $440.90, indicating a potential upside of 10.05%. Given Elevance Health's stronger consensus rating and higher probable upside, analysts clearly believe Elevance Health is more favorable than Humana.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Humana
1 Sell rating(s)
15 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.43
Elevance Health
0 Sell rating(s)
8 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.65

92.4% of Humana shares are owned by institutional investors. Comparatively, 89.2% of Elevance Health shares are owned by institutional investors. 0.2% of Humana shares are owned by company insiders. Comparatively, 0.3% of Elevance Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Humana had 32 more articles in the media than Elevance Health. MarketBeat recorded 38 mentions for Humana and 6 mentions for Elevance Health. Elevance Health's average media sentiment score of 1.34 beat Humana's score of 0.46 indicating that Elevance Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Humana
13 Very Positive mention(s)
2 Positive mention(s)
8 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Elevance Health
4 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Humana pays an annual dividend of $3.54 per share and has a dividend yield of 0.9%. Elevance Health pays an annual dividend of $6.88 per share and has a dividend yield of 1.7%. Humana pays out 33.5% of its earnings in the form of a dividend. Elevance Health pays out 30.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Elevance Health has raised its dividend for 14 consecutive years. Elevance Health is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

Elevance Health beats Humana on 15 of the 19 factors compared between the two stocks.

How does Elevance Health compare to Oscar Health?

Elevance Health (NYSE:ELV) and Oscar Health (NYSE:OSCR) are both large-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, media sentiment, dividends, institutional ownership and earnings.

89.2% of Elevance Health shares are owned by institutional investors. Comparatively, 75.7% of Oscar Health shares are owned by institutional investors. 0.3% of Elevance Health shares are owned by company insiders. Comparatively, 22.6% of Oscar Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Oscar Health has a net margin of 3.60% compared to Elevance Health's net margin of 2.47%. Oscar Health's return on equity of 38.45% beat Elevance Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Elevance Health2.47% 14.64% 5.22%
Oscar Health 3.60%38.45%6.76%

Elevance Health currently has a consensus price target of $440.90, suggesting a potential upside of 10.05%. Oscar Health has a consensus price target of $26.22, suggesting a potential downside of 19.76%. Given Elevance Health's stronger consensus rating and higher probable upside, equities research analysts clearly believe Elevance Health is more favorable than Oscar Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Elevance Health
0 Sell rating(s)
8 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.65
Oscar Health
0 Sell rating(s)
8 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.42

Elevance Health has a beta of 0.68, indicating that its stock price is 32% less volatile than the broader market. Comparatively, Oscar Health has a beta of 2.36, indicating that its stock price is 136% more volatile than the broader market.

Elevance Health has higher revenue and earnings than Oscar Health. Elevance Health is trading at a lower price-to-earnings ratio than Oscar Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Elevance Health$199.13B0.44$5.66B$22.5017.81
Oscar Health$11.70B0.86-$443.15M$1.4023.34

In the previous week, Oscar Health had 13 more articles in the media than Elevance Health. MarketBeat recorded 19 mentions for Oscar Health and 6 mentions for Elevance Health. Elevance Health's average media sentiment score of 1.34 beat Oscar Health's score of 0.92 indicating that Elevance Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Elevance Health
4 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Oscar Health
8 Very Positive mention(s)
6 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Oscar Health beats Elevance Health on 9 of the 17 factors compared between the two stocks.

Get Elevance Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for ELV and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ELV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ELV vs. The Competition

MetricElevance HealthHealthcare Providers & Services IndustryHealthcare SectorNYSE Exchange
Market Cap$86.82B$9.87B$7.03B$24.33B
Dividend Yield1.72%2.54%2.57%3.68%
P/E Ratio17.8135.17271.2630.85
Price / Sales0.444.88622.9518.01
Price / Cash10.65124.2475.7032.61
Price / Book1.933.9412.926.82
Net Income$5.66B$309.96M$3.45B$1.06B
7 Day Performance1.61%0.09%1.16%0.55%
1 Month Performance7.64%-0.34%2.17%2.70%
1 Year Performance29.71%19.48%62.38%19.14%

Elevance Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ELV
Elevance Health
4.8888 of 5 stars
$400.63
+0.6%
$440.90
+10.1%
+29.7%$86.82B$199.13B17.8197,100
CNC
Centene
3.2314 of 5 stars
$63.72
+2.4%
$68.21
+7.0%
+136.9%$31.48B$194.78BN/A61,100
MOH
Molina Healthcare
2.7394 of 5 stars
$194.68
-0.5%
$202.44
+4.0%
+26.8%$10.16B$45.43BN/A19,000
UNH
UnitedHealth Group
4.9343 of 5 stars
$415.21
+0.2%
$455.92
+9.8%
+32.1%$377.07B$447.57B26.72390,000
HUM
Humana
4.1595 of 5 stars
$374.27
+2.9%
$386.61
+3.3%
+35.4%$44.94B$129.66B35.4167,060

Related Companies and Tools


This page (NYSE:ELV) was last updated on 8/16/2026 by MarketBeat.com Staff.
From Our Partners